Cargando…

Safety of Dengue Vaccine?

Detalles Bibliográficos
Autores principales:	Biswal, Shibadas, Patel, Sanjay S, Rauscher, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938735/ https://www.ncbi.nlm.nih.gov/pubmed/36196620 http://dx.doi.org/10.1093/cid/ciac808

Ejemplares similares

97. Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View
por: Tricou, Vianney, et al.
Publicado: (2021)

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
por: Biswal, Shibadas, et al.
Publicado: (2021)

Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue
por: Sáez-Llorens, Xavier, et al.
Publicado: (2023)

Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate
por: Patel, Sanjay S, et al.
Publicado: (2022)

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)
por: Rivera, Luis, et al.
Publicado: (2021)

Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults
por: LeFevre, Inge, et al.
Publicado: (2023)

Dengue at Meerut
por: Khan, Soleiman
Publicado: (1913)

Dengue in Guzrat
por: Dalsukhram, Ganpatram
Publicado: (1913)

Dengue Fever
por: Dey, U. N.
Publicado: (1912)

Dengue and Chitral Fever
por: McCarrison, R.
Publicado: (1909)

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination
por: López-Medina, Eduardo, et al.
Publicado: (2020)

Mapping dengue cases through a national network of laboratories, 2014-2015
por: Joshua, Vasna, et al.
Publicado: (2016)

ACUTE TUBULAR NECROSIS AND DENGUE
por: Wiwanitkit, Viroj
Publicado: (2014)

FALSE-NEGATIVE DENGUE CASES
por: TIN, Sim Sai, et al.
Publicado: (2015)

Dengue or Three-Day Fever
por: Murphy, R. A.
Publicado: (1919)

Dengue and Seven-Day Fever
por: Rogers, Leonard
Publicado: (1909)

Dengue fever in Saudi Arabia
por: Joob, Beuy, et al.
Publicado: (2017)

Optical Coherence Tomography to Evaluate Dengue
por: Joob, Beuy, et al.
Publicado: (2014)

Novel coronavirus outbreak in Pakistan: Beware of dengue
por: Rana, Muhammad Suleman, et al.
Publicado: (2021)

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
por: Launay, Odile, et al.
Publicado: (2022)

Study of 110 Cases of Dengue Fever in the Madras Penitentiary
por: Karamchandani, P. V.
Publicado: (1937)

The authors’ reply to comments on “dengue management in triage using ultrasound in children from Cambodia: A prospective cohort study”
por: Gleeson, Timothy, et al.
Publicado: (2022)

Additional considerations for assessing COVID-19 impact on dengue transmission
por: Yek, Christina, et al.
Publicado: (2022)

Perspectives and lessons from the Philippines’ decades-long battle with dengue
por: Ong, Erika P., et al.
Publicado: (2022)

Emergence of dengue in Andaman & Nicobar archipelago: Eco-epidemiological perspective
por: Vijayachari, P., et al.
Publicado: (2011)

Covert COVID-19 and false-positive dengue serology in Singapore
por: Yan, Gabriel, et al.
Publicado: (2020)

Safety and efficacy of the Russian COVID-19 vaccine: more information needed
por: Bucci, Enrico, et al.
Publicado: (2020)

Sentinel surveillance at airports: Experience of dengue and COVID‐19 prevention in Taiwan
por: Chang, Ko, et al.
Publicado: (2020)

Maternal and perinatal outcome in dengue and COVID-19 co-infected pregnancies
por: Thakur, Pryanka, et al.
Publicado: (2023)

Dengue virus and its recent outbreaks: current scenario and counteracting strategies
por: Sah, Ranjit, et al.
Publicado: (2023)

Safety of yellow fever vaccine in Indian travellers: A prospective observational study
por: Tiwari, Pramil, et al.
Publicado: (2016)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Author's reply
por: Biswal, Sasmita
Publicado: (2013)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

The Co-Administration of COVID-19 and Hepatitis B Vaccines, Should Safety Be a Concern?
por: Alrashdan, Mohammad S., et al.
Publicado: (2022)

Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply
por: Logunov, Denis Y, et al.
Publicado: (2020)

Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective
por: Tariq, Javeria, et al.
Publicado: (2021)

Additional considerations for assessing COVID-19 impact on dengue transmission – Authors' reply
por: Brady, Oliver J, et al.
Publicado: (2022)

Chikungunya, zika, and dengue: Three neglected re-emerging Aedes-borne diseases
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Dengue haemorrhagic fever among adults – An observational study in Chennai, south India
por: Bhaskar, M. Emmanuel, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gnd3gite8qugenusvsmhof5tat